Estonia -
estoniană -
Ravimiamet
linezolid krka õhukese polümeerikattega tablett
krka, d.d., novo mesto - linesoliid - õhukese polümeerikattega tablett - 600mg 10tk; 600mg 20tk
Estonia -
estoniană -
Ravimiamet
orungal kõvakapsel
johnson & johnson uab - itrakonasool - kõvakapsel - 100mg 4tk; 100mg 15tk
Estonia -
estoniană -
Ravimiamet
haloperidol-richter suukaudsed tilgad, lahus
gedeon richter plc. - haloperidool - suukaudsed tilgad, lahus - 2mg 1ml 10ml 1tk
Estonia -
estoniană -
Ravimiamet
haloperidol-richter süstelahus
gedeon richter plc. - haloperidool - süstelahus - 5mg 1ml 1ml 5tk
Estonia -
estoniană -
Ravimiamet
daktarin suukaudne geel
johnson & johnson uab - mikonasool - suukaudne geel - 20mg 1g 40g 1tk
Estonia -
estoniană -
Ravimiamet
haloperidol decanoate-richter süstelahus
gedeon richter plc. - haloperidool - süstelahus - 50mg 1ml 1ml 5tk
Estonia -
estoniană -
Ravimiamet
linezolid accord infusioonilahus
accord healthcare b.v. - linesoliid - infusioonilahus - 2mg 1ml 300ml 10tk
Estonia -
estoniană -
Ravimiamet
daktarin suukaudne geel
lex ano uab - mikonasool - suukaudne geel - 20mg 1g 40g 1tk
Uniunea Europeană -
estoniană -
EMA (European Medicines Agency)
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastilised ained - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
Uniunea Europeană -
estoniană -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastilised ained - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.